Fig. 4

Comparative Gene Expression Profiles in RRMS Patients: T-bet Expression Significantly Elevated in Treatment-Naïve RRMS Patients Compared to Controls (Ctrls) and Interferon beta-1alpha (IFNβ-1a)-Treated Patients (P = 0.035 and P = 0.037, respectively). However, IFN-γ and MEG3 Expression Levels Show No Significant Differences Among These Groups. All Values Represent Mean ± SEM; *P < 0.05, ns: nonsignificant